Evaluation of Wharton’s Jelly Allografts for Structural Support in Hip Pathology
Oct 03, 2024
Evaluating Wharton’s Jelly Applications for Hip Connective Tissue Defects More than 350,000 hip replacements are performed annually in the U.S.,… Read More >
2024 Legal Opinions on the Compliance and Clinical Use of Regenative’s Wharton’s Jelly Products
Sep 26, 2024
“At Regenative, we are committed to providing the regulatory clarity and legal protection you need to focus on what matters… Read More >
Regenative Labs Returned from a Successful PAINWeek 2024
Sep 12, 2024
Regenative Labs had a very successful visit last week sponsoring PAINWeek 2024 in Las Vegas. Our team met numerous physicians,… Read More >
Join Regenative Labs at PAINWeek 2024, September 3-6, at The Cosmopolitan, Las Vegas
Aug 30, 2024
Regenative Labs is excited to announce our participation in PAINWeek 2024, taking place from September 3-6 at The Cosmopolitan in… Read More >
Retrospective Study: Umbilical Cord Tissue in TMJ Defects
Nov 15, 2023
An Option for Temporomandibular Joint Cartilage Defects Temporomandibular Dysfunction (TMD) can affect the bone, muscle, and connective tissues of the… Read More >
Regenative Labs & Brothers in Arms: $5M Partnership for Veteran Care
Sep 29, 2023
PENSACOLA, Fla. , Feb. 27, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, is partnering with Brothers in Arms Foundation (BIAF), a… Read More >
A Letter From Our CEO for Regenerative Medicine
Aug 16, 2023
Tyler Barrett has served as Chief Executive Officer of Regenative Labs for the past three years. With extensive experience as… Read More >
Regenative Labs: Wharton’s Jelly Study on TMJ Defects
Jun 02, 2023
PENSACOLA, Fla., May 30, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, announces one of its observational study… Read More >
Cryopreserved Human Umbilical Cord Tissue Allografts in Providing Structural Support for Sacroiliac Joint Pathology: A Case Series
Mar 02, 2023
Abstract This IRB-approved retrospective study reviewed patient-reported outcomes following Wharton’s Jelly (WJ) birth tissue allograft applications in 38 individuals experiencing… Read More >